Tower Research Capital LLC (Trc) Tff Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.31 - $0.48 $631 - $978	2,038 Added 17.21%	13,879 $4,000
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.77 $1,167 - $2,089	-2,714 Reduced 18.65%	11,841 $5,000
Q1 2023 May 09, 2023	BUY	$0.62 - $1.1 $6,098 - $10,820	9,837 Added 208.5%	14,555 $10,000
Q4 2022 Feb 10, 2023	BUY	$0.84 - $100.75 $252 - $30,225	300 Added 6.79%	4,718 $5,000
Q3 2022 Nov 10, 2022	SELL	$4.61 - $116.0 $1,512 - $38,048	-328 Reduced 6.91%	4,418 $18,000
Q2 2022 Aug 15, 2022	SELL	$3.99 - $7.22 $9,049 - $16,374	-2,268 Reduced 32.34%	4,746 $27,000
Q1 2022 May 12, 2022	BUY	$5.28 - $9.17 $30,138 - $52,342	5,708 Added 437.06%	7,014 $44,000
Q4 2021 Feb 14, 2022	BUY	$6.86 - $9.65 $8,959 - $12,602	1,306 New	1,306 $11,000
Q3 2021 Nov 15, 2021	SELL	$7.21 - $10.49 $38,039 - $55,345	-5,276 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.48 - $13.61 $37,083 - $59,516	4,373 Added 484.27%	5,276 $50,000
Q1 2021 May 17, 2021	BUY	$12.96 - $19.75 $7,814 - $11,909	603 Added 201.0%	903 $12,000
Q4 2020 Feb 16, 2021	BUY	$12.74 - $18.49 $3,822 - $5,546	300 New	300 $4,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.